Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Loperamide hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for loperamide hydrochloride and what is the scope of loperamide hydrochloride patent protection?

Loperamide hydrochloride
is the generic ingredient in six branded drugs marketed by Teva, Able, Wockhardt, L Perrigo Co, Janssen Pharms, Mylan, Perrigo, J And J Consumer Inc, Aurobindo Pharma Ltd, Hi Tech Pharma, Contract Pharmacal, Bionpharma Inc, Watson Labs, Allied Pharma Inc, Roxane, Alpharma Us Pharms, Duramed Pharms Barr, Ohm Labs, Perrigo R And D, Sandoz, LNK, and Sun Pharm Inds Ltd, and is included in thirty-two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for loperamide hydrochloride. One hundred and eighteen suppliers are listed for this compound.

Summary for Generic Name: loperamide hydrochloride

Drug Master File Entries: see list11
Suppliers / Packagers: see list118
Bulk Api Vendors: see list52
Clinical Trials: see list1,010
Patent Applications: see list4,764
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:loperamide hydrochloride at DailyMed

Pharmacology for Ingredient: loperamide hydrochloride

Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc
loperamide hydrochloride
SOLUTION;ORAL019487-001Mar 1, 1988OTCYesYes► Subscribe► Subscribe
J And J Consumer Inc
loperamide hydrochloride
TABLET, CHEWABLE;ORAL020448-001Jul 24, 1997DISCNYesNo6,814,978► SubscribeY ► Subscribe
L Perrigo Co
loperamide hydrochloride
TABLET;ORAL075232-001Jan 6, 2000OTCNoNo► Subscribe► Subscribe
Watson Labs
loperamide hydrochloride
SOLUTION;ORAL073062-001May 28, 1993DISCNNoNo► Subscribe► Subscribe
loperamide hydrochloride
SOLUTION;ORAL073243-001Jan 21, 1992OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus